Inventiva S.A. Files May 2024 Report (6-K)
Ticker: IVEVF · Form: 6-K · Filed: May 30, 2024 · CIK: 1756594
| Field | Detail |
|---|---|
| Company | Inventiva S.A. (IVEVF) |
| Form Type | 6-K |
| Filed Date | May 30, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, sec-filing, pharmaceutical
TL;DR
Inventiva S.A. filed its monthly 6-K, confirming it's a 20-F filer.
AI Summary
Inventiva S.A. filed a Form 6-K on May 30, 2024, to report its activities for the month of May 2024. The company, based in Daix, France, is a pharmaceutical preparations issuer and is submitting this report under the 1934 Securities Exchange Act. Inventiva S.A. is filing its annual report under cover of Form 20-F.
Why It Matters
This filing provides an update on Inventiva S.A.'s ongoing activities and compliance with SEC reporting requirements for foreign private issuers.
Risk Assessment
Risk Level: low — This is a routine reporting form (6-K) that does not contain new material financial or operational information.
Key Players & Entities
- Inventiva S.A. (company) — Registrant
- May 2024 (date) — Reporting period
- 20240530 (date) — Filing date
- 50 RUE DE DIJON (address) — Company address
- DAIX (location) — Company city
- France (location) — Company country
- Form 6-K (document) — Filing type
- Form 20-F (document) — Annual report cover
FAQ
What is the primary purpose of this Form 6-K filing by Inventiva S.A.?
The Form 6-K is filed to report Inventiva S.A.'s activities for the month of May 2024 and to confirm it files annual reports under cover of Form 20-F.
What is Inventiva S.A.'s principal executive office address?
Inventiva S.A.'s principal executive offices are located at 50 rue de Dijon, 21121 Daix, France.
Under which act is Inventiva S.A. filing this report?
Inventiva S.A. is filing this report pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
What is the SIC code for Inventiva S.A.?
The Standard Industrial Classification (SIC) code for Inventiva S.A. is 2834, which corresponds to Pharmaceutical Preparations.
Does Inventiva S.A. file its annual reports on Form 20-F or Form 40-F?
Inventiva S.A. indicates by check mark that it files annual reports under cover of Form 20-F.
Filing Stats: 186 words · 1 min read · ~1 pages · Grade level 9 · Accepted 2024-05-30 06:05:06
Filing Documents
- f6k_053024.htm (6-K) — 5KB
- exh_991.htm (EX-99.1) — 15KB
- 0001171843-24-003163.txt ( ) — 21KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Inventiva S.A. (Registrant) Date: May 30, 2024 /s/ Frdric Cren Frdric Cren Chief Executive Officer